{
  "id": 2599,
  "label": "sodium channel inhibitor therapy",
  "model": {
    "label": "Mondo Disease Ontology (MONDO)",
    "source": 0
  },
  "type_id": 0,
  "reference_id": "MAXO:0000208",
  "properties": {
    "definition": "Use of a drug that inhibits sodium influx through cell membranes."
  },
  "isLeaf": true,
  "isRoot": false,
  "child_count": 0,
  "parents": [
    {
      "id": 2584,
      "label": "anticonvulsant agent therapy",
      "isLeaf": false,
      "isRoot": false,
      "parents": [
        2605
      ],
      "type_id": 0,
      "properties": {
        "definition": "Treatment with a drug used to prevent seizures or reduce their severity."
      },
      "child_count": 2,
      "reference_id": "MAXO:0000167"
    },
    {
      "id": 2624,
      "label": "molecular pathway modifying agent therapy",
      "isLeaf": false,
      "isRoot": false,
      "parents": [
        2575
      ],
      "type_id": 0,
      "properties": {
        "definition": "Treatment with an agent that modifies a particular molecular pathway."
      },
      "child_count": 4,
      "reference_id": "MAXO:0000644"
    }
  ],
  "children": [],
  "roots": [
    {
      "id": 2584,
      "label": "anticonvulsant agent therapy"
    },
    {
      "id": 2624,
      "label": "molecular pathway modifying agent therapy"
    }
  ]
}